Peccatori FA - Search Results

1

Restoring platinum sensitivity in recurrent ovarian cancer by extending the platinum-free interval: Myth or reality?

Tomao F, D'Incalci M, Biagioli E, Peccatori FA, Colombo N. Tomao F, et al. Among authors: peccatori fa. Cancer. 2017 Sep 15;123(18):3450-3459. doi: 10.1002/cncr.30830. Epub 2017 Jul 5. Cancer. 2017. PMID: 28678350 Free article. Review.

2

Anti-tumor and immunomodulatory activity of intraperitoneal IFN-gamma in ovarian carcinoma patients with minimal residual tumor after chemotherapy.

Colombo N, Peccatori F, Paganin C, Bini S, Brandely M, Mangioni C, Mantovani A, Allavena P. Colombo N, et al. Int J Cancer. 1992 Apr 22;51(1):42-6. doi: 10.1002/ijc.2910510109. Int J Cancer. 1992. PMID: 1563843

3

Malignant behavior and resistance to cisplatin of human ovarian carcinoma xenografts established from the same patient at different stages of the disease.

Masazza G, Lucchini V, Tomasoni A, Peccatori F, Lampasona V, Giudici G, Mangioni C, Biondi A, Giavazzi R. Masazza G, et al. Cancer Res. 1991 Dec 1;51(23 Pt 1):6358-62. Cancer Res. 1991. PMID: 1933898

4

Intraperitoneal recombinant gamma-interferon in patients with recurrent ascitic ovarian carcinoma: modulation of cytotoxicity and cytokine production in tumor-associated effectors and of major histocompatibility antigen expression on tumor cells.

Allavena P, Peccatori F, Maggioni D, Erroi A, Sironi M, Colombo N, Lissoni A, Galazka A, Meiers W, Mangioni C, et al. Allavena P, et al. Cancer Res. 1990 Nov 15;50(22):7318-23. Cancer Res. 1990. PMID: 2121337 Clinical Trial.

5

Pure ovarian immature teratoma, a unique and curable disease: 10 years' experience of 32 prospectively treated patients.

Bonazzi C, Peccatori F, Colombo N, Lucchini V, Cantù MG, Mangioni C. Bonazzi C, et al. Obstet Gynecol. 1994 Oct;84(4):598-604. Obstet Gynecol. 1994. PMID: 7522313

6

Surgical management of malignant ovarian germ-cell tumors: 10 years' experience of 129 patients.

Peccatori F, Bonazzi C, Chiari S, Landoni F, Colombo N, Mangioni C. Peccatori F, et al. Obstet Gynecol. 1995 Sep;86(3):367-72. doi: 10.1016/0029-7844(95)00192-T. Obstet Gynecol. 1995. PMID: 7651644

7

Mammaglobin expression in leukapheresis products is a predictive marker of poor prognosis in women with high-risk breast cancer.

Ferrucci PF, Rabascio C, Mazzetta C, Cocorocchio E, Agazzi A, Vanazzi A, Cinieri S, Peccatori FA, Paolucci M, Bertolini F, Martinelli G. Ferrucci PF, et al. Among authors: peccatori fa. Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6039-46. doi: 10.1158/1078-0432.CCR-03-0453. Clin Cancer Res. 2004. PMID: 15447988

8

Weekly epirubicin in the treatment of gestational breast cancer (GBC).

Peccatori FA, Azim HA Jr, Scarfone G, Gadducci A, Bonazzi C, Gentilini O, Galimberti V, Intra M, Locatelli M, Acaia B, Rossi P, Cinieri S, Calabrese L, Goldhirsch A. Peccatori FA, et al. Breast Cancer Res Treat. 2009 Jun;115(3):591-4. doi: 10.1007/s10549-008-0159-2. Epub 2008 Aug 20. Breast Cancer Res Treat. 2009. PMID: 18712595

9

Are monoclonal antibodies a safe treatment for cancer during pregnancy?

Sarno MA, Mancari R, Azim HA Jr, Colombo N, Peccatori FA. Sarno MA, et al. Among authors: peccatori fa. Immunotherapy. 2013 Jul;5(7):733-41. doi: 10.2217/imt.13.64. Immunotherapy. 2013. PMID: 23829624 Review.

10

Treatment options for pregnant women with ovarian tumors.

Mancari R, Tomasi-Cont N, Sarno MA, Azim HA Jr, Franchi D, Carinelli S, Biglia N, Colombo N, Peccatori FA. Mancari R, et al. Among authors: peccatori fa. Int J Gynecol Cancer. 2014 Jul;24(6):967-72. doi: 10.1097/IGC.0000000000000161. Int J Gynecol Cancer. 2014. PMID: 24978707 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

248 results

Search Page